| Patents for A61K 101 - Radioactive non-metals (526) |
|---|
| 09/03/2008 | EP1962911A2 Novel imaging agents for fibrosis |
| 08/28/2008 | US20080206134 Radio-opaque hemostatic agents and devices and methods for the delivery thereof |
| 08/13/2008 | EP1791571B1 Radiofluorinated peptides |
| 07/31/2008 | WO2008091195A1 Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives |
| 07/16/2008 | EP1942950A2 Biodegradable composite for internal local radiotherapy |
| 07/10/2008 | WO2008083056A2 Ligands for imaging cardiac innervation |
| 07/10/2008 | WO2008083054A2 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure |
| 07/02/2008 | CN101210016A Heterocycle-fused morphinans compounds, preparation method and use thereof |
| 06/26/2008 | WO2008075040A2 Radioactive pet agents for imaging ccr5 in vivo |
| 06/12/2008 | US20080138282 Radiolabeled Arylsulfonyl Compounds and Uses Thereof |
| 05/22/2008 | US20080118435 Composition comprising low density microspheres |
| 05/21/2008 | CN101182349A Recombinant octreotide and uses thereof |
| 05/14/2008 | EP1920786A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 05/07/2008 | CN101172162A Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 05/06/2008 | US7368474 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide |
| 04/30/2008 | CN101168554A Method for preparing 18F-FLT |
| 04/10/2008 | WO2007066119A3 Novel imaging agents for fibrosis |
| 04/09/2008 | CN101157649A 18F-Fallypride automatically synthesizing method |
| 04/09/2008 | CN101157648A Method for purifying 18F-Fallypride marker precursor compound |
| 04/02/2008 | CN101153013A Method of producing DL-tyrosine -**N |
| 03/26/2008 | CN101151054A Radiofluorinated peptides |
| 03/18/2008 | US7344705 Composition comprising low density microspheres |
| 03/05/2008 | EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents |
| 02/27/2008 | CN101130506A Synthesis method of image agent used for diagnosis of progeria dementia |
| 02/20/2008 | CN101125208A Apatite developer and its positron emitting tomography imaging |
| 02/13/2008 | CN101121713A Method for preparing 2beta-carbonyl-3beta-(4-chlorobenzo)-8-(2-fluoro[18F]ethyl)demethyltropane by one-step method |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/31/2008 | WO2007052267A3 Biodegradable composite for internal local radiotherapy |
| 01/16/2008 | CN101104627A 18F-FDG automatization synthetic method and device |
| 01/10/2008 | WO2008003954A1 Dye imaging agents |
| 12/19/2007 | CN101089020A VIP analog and its radioactive marker and their prepn process |
| 11/21/2007 | CN101074231A [18F] fluoraro-marked purine compound, its production and use |
| 11/01/2007 | US20070253899 Dual Function Polymer Micelles |
| 10/18/2007 | US20070243134 Receptor Selective Cannabimimetic Aminoalkylindoles |
| 10/17/2007 | CN100342916C Biodegradable medical material marker and preparation thereof |
| 10/03/2007 | EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 09/05/2007 | CN101028525A Use of tumor caryon single-antibody in physical therapeutic tumor as synergist |
| 08/23/2007 | WO2006036269A3 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof |
| 08/01/2007 | EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007777A (s)-(-)-5-tributyltin-N-[(1-allyl-2-pyrrolidinyl)methyl]-2,3-dimethoxybenzamide preparation method |
| 07/25/2007 | CN101002952A Contrast medium for gastrointestinal tract |
| 07/11/2007 | CN1995020A Radioactive iodine-17- allylamino-17-demethoxygeldanamycin and its preparation method |
| 06/27/2007 | CN1985997A Degradable radioactive sponge and its making process |
| 06/20/2007 | EP1796737A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof |
| 06/14/2007 | WO2006030291A3 Radiofluorinated peptides |
| 06/13/2007 | CN1321127C Iodine (I)-23-hydroxyl betulinic acid, rpeparation method and application thereof |
| 06/06/2007 | EP1791571A2 Radiofluorinated peptides |
| 06/06/2007 | CN1974587A Basic hydrolysis process for preparing 2-fluoro [18F]-2-deoxy-beta-D-glucose in single tube FDG acidic hydrolysis apparatus |
| 05/23/2007 | CN1966140A Chemical synthesizer capable of preparing multiple fluoro-marking agent |
| 05/16/2007 | CN1962659A 2- fluoro -N,N- dimethyl -2-(6-methyl-2-p-tolylimidazole [1,2-a] pyridine)-3- acetamide compound and its preparation method |
| 05/10/2007 | WO2007052267A2 Biodegradable composite for internal local radiotherapy |
| 05/09/2007 | CN1958615A Antibody of anti human CD20 from human resources functionally, and application |
| 05/02/2007 | EP1778300A1 Personal cleansing composition containing a per-alk(en)yl hydrocarbon material |
| 04/18/2007 | CN1948311A 2-iodine substituted phenyl-6-trifluoro methyl imidazole [1,2-a]-pyridine-3-acetamide compounds and its preparation method |
| 04/05/2007 | WO2006084030B1 Small-molecule hsp90 inhibitors |
| 02/28/2007 | EP1275645B1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system |
| 02/21/2007 | EP1753467A1 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911952A Preparation technology of 18F labelled positive electron radioactivity tracer precusor |
| 02/14/2007 | CN1911947A Synthesis technology of 18F labelled positive electron radioactive tracer precusor |
| 02/14/2007 | CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/25/2007 | WO2006084030A3 Small-molecule hsp90 inhibitors |
| 01/25/2007 | WO2006070290A8 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/10/2007 | EP1740225A2 Contrast agents for myocardial perfusion imaging |
| 01/04/2007 | WO2006116629A3 The preparation of molecular imaging probes using click chemistry |
| 01/03/2007 | CN1887829A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
| 12/13/2006 | EP1729824A2 Phospholipid analogs for diagnosis and treatment of cancer |
| 11/22/2006 | CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution |
| 11/15/2006 | CN1861201A Medical implant of sodium iodide and its prepn. method |
| 11/02/2006 | WO2006070290A3 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/31/2006 | EP1660519A2 Fluorinated carbohydrate conjugates |
| 05/10/2006 | CN1771058A Microwave method for preparing radiolabelled gallium complexes |
| 04/12/2006 | EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity |
| 03/22/2006 | CN1246042C Preparation method of therapy used iodine-125 sealed seed source core |
| 02/16/2006 | US20060034772 Composition comprising low density microspheres |
| 02/15/2006 | EP1624901A2 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals |
| 02/14/2006 | US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
| 01/18/2006 | EP1615671A1 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 11/11/2004 | US20040223914 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
| 08/10/2004 | US6773696 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 03/17/2004 | EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 08/26/2003 | US6610270 In vivo determination of metabolic function for use in therapy management |
| 03/20/2003 | US20030053953 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region |
| 03/04/2003 | US6528039 Low density microspheres and their use as contrast agents for computed tomography and in other applications |
| 01/15/2003 | EP1275645A1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system |
| 01/02/2003 | EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 12/04/2002 | EP1262490A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 04/30/2002 | US6379649 Useful for diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors; nerve system disporders |
| 09/27/2001 | US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue |
| 09/04/2001 | US6284219 In vivo determination of metabolic function for use in therapy management |
| 07/03/2001 | CA2107466C Low density microspheres and their use as contrast agents for computed tomography |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 04/11/2001 | EP1089765A2 $i(IN VIVO) DETERMINATION OF METABOLIC FUNCTION FOR USE IN THERAPY MANAGEMENT |
| 01/31/2001 | EP1071684A1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |